Healthcare providers monitor adverse events through regular patient assessments, including physical examinations, laboratory tests, and imaging studies. Patients are also encouraged to report any new or worsening symptoms. This data is often collected in clinical trials and post-marketing surveillance programs to assess the safety profile of cancer therapies.
